SpaceX’s record IPO closed on June 12 at a reported ~$2.1T valuation, but the article argues the stock is vulnerable to large swings due to expensive pricing versus its revenue base. It highlights Rocket Lab (35 launches vs SpaceX’s 260 in the past 18 months) with a growing $2.2B backlog ($1.3B from space systems), including a $190M contract for 20 hypersonic test flights. For a more defensive alternative, it profiles Lockheed Martin as Orion prime contractor and points to a 2.7% dividend yield that has been grown for 23 years, positioning it as benefiting from long-duration space and defense budgets amid geopolitical uncertainty.
The better read-through is not that "space" is broadly bullish; it is that the public market now has a very visible valuation benchmark for a business model that private-market investors have treated as scarcity-driven. That tends to raise the bar for every listed name: launch-only companies get measured against scale and cadence they cannot match, while the market becomes less tolerant of execution misses. In that setup, the first-order beneficiary is usually the incumbent with diversified defense cash flows, not the pure growth story.
Rocket Lab’s real value is increasingly in the non-launch mix. If management can keep converting the systems backlog into higher-margin recurring hardware and software revenue, the stock can de-risk from a "single-rocket story" into a defense supplier with launch optionality; if not, SpaceX’s dominance becomes a pricing anchor that suppresses the multiple. The key second-order effect is procurement behavior: any push for second-source resilience, hypersonic testing, or sovereign launch capacity helps RKLB, but only if government demand offsets launch pricing pressure over the next 1-3 quarters.
Lockheed is the cleaner way to own space exposure because the space franchise sits inside a broader, less cyclical earnings base. The market may underappreciate how much a rising defense budget plus long-duration space programs can support backlog visibility and dividend support even if pure space enthusiasm fades. The risk is that this is already partly embedded in the multiple; the upside comes more from sustained budget growth and program execution than from hype.
Contrarian view: the consensus may be overestimating how much a flashy private-market event translates into public-equity alpha. If investor attention rotates toward the new IPO while public comps are forced to prove margins, RKLB can lag before it wins on fundamentals. Falsifiers are simple: a slowdown in RKLB backlog conversion or launch cadence over the next 1-2 quarters, or any signal that defense/spend growth stalls for LMT over the next budget cycle.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
